bpc-157 fda ind or nda to Reconsider and Other Peptides | Ashish Talati posted on the topic The date is locked in
The date is locked in for LGMD2I R9. The FDA has accepted our NDA for BBP 418 for LGMD2I R9, with a PDUFA target action date of November 27, 2026. For a community that has Is BPC 157 Banned? Oral vs. Injectable Forms Explained TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on biopharma #regulatoryaffairs #lifesciences #bostonbiodevelopment #fdaapproval Boston Biodevelopment LLC FDA Peptide Regulations 2026: What Patients Need to Know
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

